Asthma News – January 28, 2022
Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff.
Sign up to receive weekly-ish news emails.
Check out the most recent
MDHHS asthma social media messages and share them with your networks.
The Keep MI Kids Tobacco Free Alliance includes a wide variety of public health organizations and associations, hospital systems and education groups and is chaired by leaders from the Campaign for Tobacco Free-Kids and the Michigan Chapter of American Academy of Pediatrics. This group strengthens Michigan’s tobacco control laws, keep tobacco products out of the hands of youth and help adults quit. Join today!
The Smoking Cessation Leadership Center at UCSF is hosting a webinar that will describe research definitions of Health Disparities and Equity Research, identify two ways how tobacco use behavior varies by race and ethnicity, explain tailored cessation approaches by race and ethnicity and identify data on health disparities related to the COVID-19 and tobacco smoking. CME/CEU available.
This year's report shows significant progress in reducing tobacco use over the past 20 years. However, a new generation of tobacco products, especially e-cigarettes and flavored tobacco products, threatens that progress.
How did Michigan do?
A new study that tracked 68.5 million Medicare recipients showed that senior citizens who breathe in even low levels of pollution from industry, traffic, wildfires and other sources face greater odds of dying earlier as a result, and incremental changes in allowable emissions could save lives.
Greenlink used its award-winning ATHENIA model to demonstrate how a clean energy transition for Michigan would impact energy bills, utility finances, statewide economic benefits and pollution-related health effects compared to the status quo, concluding that for every $1 invested in a clean energy transition, $7.70 benefits would be achieved statewide.
A new study found that the use of diagnostic tools, such as a spirometer, for asthma diagnosis was compatible with the guidelines. While recent updates of the guidelines indicate that salbutamol (albuterol) should not be used solely in mild asthmatics due to its harmful effects in long-term use, it still was the most preferred drug by pulmonologists.